Clinical Trial Update: Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of adding vildagliptin to sulphonylurea and metformin in type 2 diabetes; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes | Phase 4 | Status: COMPLETED